1-16 of 16
John C. Morris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5925: A novel oncolytic adenovirus for radioiodine therapy and imaging

Free
Lisa Koodie, Eriko Iguchi Kawakami, Kari Jacobsen, Zuzan Cayci, Andrew Taylor, Edward W. Greeno, Robert J. Schumacher, John C. Morris, Martin E. Fernandez-Zapico, Julia Davydova
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5925.
https://doi.org/10.1158/1538-7445.AM2018-5925
Published: 01 July 2018
View articletitled, Abstract 5925: A novel oncolytic adenovirus for radioiodine therapy and imaging
Journal Articles

Abstract 4629: Physiologically based pharmacokinetic model and correlative in vitro assessment of metabolism-based interaction between Everolimus and PI3K/mTOR inhibitor BEZ235

Free
Ganesh P. Moorthy, Bilal Abuasal, Larry Sallans, John C. Morris, George Thomas, Pankaj B. Desai
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4629.
https://doi.org/10.1158/1538-7445.AM2014-4629
Published: 01 October 2014
View articletitled, Abstract 4629: Physiologically based pharmacokinetic model and correlative in vitro assessment of metabolism-based interaction between Everolimus and PI3K/mTOR inhibitor BEZ235
Journal Articles

Abstract 2575: Results from the first-in-human phase I trials of recombinant human Interleukin 15 (rhIL-15) administered as a daily 30 minute intravenous infusion (IVB) for 12 consecutive days or as continuous intravenous infusion (CIV) for 240 hours in patients with refractory metastatic cancers

Free
Kevin C. Conlon, Enrico Lugli, Steven A. Rosenberg, John C. Morris, Thomas Fleisher, Hugh Welles, Sigrid Dubois, Liyanage Perera, Carolyn Goldman, Bonita Bryant, Jean Decker, Joanna Shih, Tat'Yana Worthy, William Figg, Cody Peer, Michael Sneller, H. Clifford Lane, Jason Yovandich, Stephen Creekmore, Mario Roederer, Thomas A. Waldmann
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2575.
https://doi.org/10.1158/1538-7445.AM2014-2575
Published: 01 October 2014
View articletitled, Abstract 2575: Results from the first-in-human phase I trials of recombinant human Interleukin 15 (rhIL-15) administered as a daily 30 minute intravenous infusion (IVB) for 12 consecutive days or as continuous intravenous infusion (CIV) for 240 hours in patients with refractory metastatic cancers
Journal Articles

Abstract 5507: Immunological findings in a phase II immunotherapy study using allogeneic lung cancer cells modified to express alpha(1,3)galactosyltransferase in advanced non-small cell lung cancer (NSCLC)

Free
Gabriela R. Rossi, Nicholas N. Vahanian, John C. Morris, Jay W. Ramsey, Lucinda Tennant, Charles J. Link
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5507.
https://doi.org/10.1158/1538-7445.AM2011-5507
Published: 15 April 2011
View articletitled, Abstract 5507: Immunological findings in a phase II immunotherapy study using allogeneic lung cancer cells modified to express alpha(1,3)galactosyltransferase in advanced non-small cell lung cancer (NSCLC)
Journal Articles

Abstract 5392: Mesenchymal stem cell (MSC) mediated delivery of the sodium iodide symporter (NIS) supports radionuclide imaging and treatment of breast cancer

Free
Roisin M. Dwyer, James Ryan, Ronan Havelin, John C. Morris, Cathal O'Flatharta, Brian Miller, Zhonglin Liu, Mark Foley, Harrison H. Barrett, Mary Murphy, Frank P. Barry, Timothy O'Brien, Michael J. Kerin
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5392.
https://doi.org/10.1158/1538-7445.AM2011-5392
Published: 15 April 2011
View articletitled, Abstract 5392: Mesenchymal stem cell (MSC) mediated delivery of the sodium iodide symporter (NIS) supports radionuclide imaging and treatment of breast cancer
Journal Articles

Abstract 2423: Phase I/II study of antitumor vaccination using lung cancer cells expressing murine α(1,3)galactosyltransferase (αGT) in non-small cell lung cancer (NSCLC)

Free
John C. Morris, Gabriela R. Rossi, John E. Janik, Nancy Harold, Stefania Pittaluga, Anatoli Malyguine, Susan Strobl, Lucinda Tennant, Nicholas Vahanian, Charles J. Link
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2423.
https://doi.org/10.1158/1538-7445.AM10-2423
Published: 15 April 2010
View articletitled, Abstract 2423: Phase I/II study of antitumor vaccination using lung cancer cells expressing murine α(1,3)galactosyltransferase (αGT) in non-small cell lung cancer (NSCLC)
Journal Articles

Abstract 2526: CP690550 inhibits interleukin-2 (IL-2), IL-9 and IL-15 mediated JAK3 activation and proliferation of T cells obtained from patients with HTLV-1-associated adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Free
Wei Ju, Meili Zhang, Bonita R. Bryant, Jing Chen, John C. Morris, John E. Janik, Thomas A. Waldmann, Jian-kang Jiang, Craig J. Thomas, Steven Jacobson, Unsong Oh
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2526.
https://doi.org/10.1158/1538-7445.AM10-2526
Published: 15 April 2010
View articletitled, Abstract 2526: CP690550 inhibits interleukin-2 (IL-2), IL-9 and IL-15 mediated JAK3 activation and proliferation of T cells obtained from patients with HTLV-1-associated adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Journal Articles

Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the neu Oncogene through the Induction of Antibodies Partially Independent of CD4 Help

Available to Purchase
Jason C. Steel, Charmaine A. Ramlogan, Ping Yu, Yoshio Sakai, Guido Forni, Thomas A. Waldmann, John C. Morris
Journal: Cancer Research
Cancer Res (2010) 70 (3): 1072–1081.
https://doi.org/10.1158/0008-5472.CAN-09-1301
Published: 31 January 2010
View articletitled, Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the neu Oncogene through the Induction of Antibodies Partially Independent of CD4 Help
Open the PDF for Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the neu Oncogene through the Induction of Antibodies Partially Independent of CD4 Help in another window
Journal Articles

Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/neu Vaccine

Available to Purchase
Jong Myun Park, Masaki Terabe, Jason C. Steel, Guido Forni, Yoshio Sakai, John C. Morris, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2008) 68 (6): 1979–1987.
https://doi.org/10.1158/0008-5472.CAN-07-5688
Published: 13 March 2008
View articletitled, Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/neu Vaccine
Open the PDF for Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/neu Vaccine in another window
Journal Articles

Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice

Available to Purchase
Yoshio Sakai, Brian J. Morrison, J. Douglas Burke, Jong-Myun Park, Masaki Terabe, John E. Janik, Guido Forni, Jay A. Berzofsky, John C. Morris
Journal: Cancer Research
Cancer Res (2004) 64 (21): 8022–8028.
https://doi.org/10.1158/0008-5472.CAN-03-3442
Published: 01 November 2004
View articletitled, Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice
Open the PDF for Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice in another window
Journal Articles

Lymphatic drainage imaging of the breast cancer in mice using the micro-magnetic resonance mammo-lymphangiography using a nano-size contrast agent

Free
Hisataka Kobayashi, Satomi Kawamoto, Yoshio Sakai, Peter L. Choyke, Martin W. Brechbiel, John C. Morris, Thomas A. Waldmann
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1305.
Published: 01 April 2004
View articletitled, Lymphatic drainage imaging of the breast cancer in mice using the micro-magnetic resonance mammo-lymphangiography using a nano-size contrast agent
Journal Articles

Probasin Promoter (ARR2PB)-Driven, Prostate-Specific Expression of the Human Sodium Iodide Symporter ( h-NIS ) for Targeted Radioiodine Therapy of Prostate Cancer

Available to Purchase
Hideaki Kakinuma, Elizabeth R. Bergert, Christine Spitzweg, John C. Cheville, Michael M. Lieber, John C. Morris
Journal: Cancer Research
Cancer Res (2003) 63 (22): 7840–7844.
Published: 21 November 2003
View articletitled, Probasin Promoter (ARR2PB)-Driven, Prostate-Specific Expression of the Human Sodium Iodide Symporter ( h-NIS ) for Targeted Radioiodine Therapy of Prostate Cancer
Open the PDF for Probasin Promoter (ARR2PB)-Driven, Prostate-Specific Expression of the Human Sodium Iodide Symporter ( h-NIS ) for Targeted Radioiodine Therapy of Prostate Cancer in another window
Journal Articles

Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter

Available to Purchase
Christine Spitzweg, Michael K. O’Connor, Elizabeth R. Bergert, Donald J. Tindall, Charles Y. F. Young, John C. Morris
Journal: Cancer Research
Cancer Res (2000) 60 (22): 6526–6530.
Published: 15 November 2000
View articletitled, Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter
Open the PDF for Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter in another window
Journal Articles

The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity

Available to Purchase
Oliver Wildner, John C. Morris
Journal: Cancer Research
Cancer Res (2000) 60 (15): 4167–4174.
Published: 01 August 2000
View articletitled, The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity
Open the PDF for The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity in another window
Journal Articles

Prostate-specific Antigen (PSA) Promoter-driven Androgen-inducible Expression of Sodium Iodide Symporter in Prostate Cancer Cell Lines

Available to Purchase
Christine Spitzweg, Shaobo Zhang, Elizabeth R. Bergert, Maria R. Castro, Bryan McIver, Armin E. Heufelder, Donald J. Tindall, Charles Y. F. Young, John C. Morris
Journal: Cancer Research
Cancer Res (1999) 59 (9): 2136–2141.
Published: 01 May 1999
View articletitled, Prostate-specific Antigen (PSA) Promoter-driven Androgen-inducible Expression of Sodium Iodide Symporter in Prostate Cancer Cell Lines
Open the PDF for Prostate-specific Antigen (PSA) Promoter-driven Androgen-inducible Expression of Sodium Iodide Symporter in Prostate Cancer Cell Lines in another window
Journal Articles

Therapy of Colon Cancer with Oncolytic Adenovirus Is Enhanced by the Addition of Herpes Simplex Virus-thymidine kinase

Available to Purchase
Oliver Wildner, R. Michael Blaese, John C. Morris
Journal: Cancer Research
Cancer Res (1999) 59 (2): 410–413.
Published: 15 January 1999
View articletitled, Therapy of Colon Cancer with Oncolytic Adenovirus Is Enhanced by the Addition of Herpes Simplex Virus-thymidine kinase
Open the PDF for Therapy of Colon Cancer with Oncolytic Adenovirus Is Enhanced by the Addition of Herpes Simplex Virus-thymidine kinase in another window